bucindolol has been researched along with Ventricular Dysfunction, Left in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (70.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aleong, RG; Bristow, MR; Davis, G; Sauer, WH | 1 |
| Adams, KF | 1 |
| Remme, WJ | 1 |
| Francis, GS; Sarraf, M | 1 |
| Ball, S; Berning, J; Brendorp, B; Carlsen, J; Eberle, S; Hall, A; Hampton, J; Jensen, G; Køber, L; Ottesen, M; Torp-Pedersen, C; Zilles, P | 1 |
| Adams, K; Ghali, JK; Goldman, S; Khan, S; Krause-Steinrauf, HJ; Larsen, RL; Lindenfeld, J; Lowes, B; Peberdy, MA; Rosenberg, YD; Thaneemit-Chen, S; Yancy, C; Young, J | 1 |
| Coffey, CS; Curtis, JP; Foody, JM; Hebert, PR; Ko, DT; Krumholz, HM; Sedrakyan, A | 1 |
| Coutinho, J | 1 |
| Czuriga, I; Edes, I | 1 |
| Yancy, CW | 1 |
5 review(s) available for bucindolol and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Beta-blockers in heart failure: how far have we progressed?
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Bisoprolol; Carbazoles; Carvedilol; Contraindications; Heart Failure; Humans; Metoprolol; Propanolamines; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2002 |
β-blockers in stage B: a precursor of heart failure.
Topics: Adrenergic beta-Antagonists; Animals; Benzazepines; Bisoprolol; Carbazoles; Cardiovascular System; Carvedilol; Disease Progression; Heart Failure; Heart Ventricles; Humans; Ivabradine; Propanolamines; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2012 |
[Adrenergic beta inhibitors in heart insufficiency: which and when?].
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Heart Failure; Humans; Metoprolol; Patient Selection; Propanolamines; Randomized Controlled Trials as Topic; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2001 |
[Role of beta-blockers in the treatment of chronic heart heart failure].
Topics: Adrenergic beta-Antagonists; Bisoprolol; Carbazoles; Carvedilol; Chronic Disease; Controlled Clinical Trials as Topic; Disease Progression; Drug Administration Schedule; Heart Failure; Humans; Metoprolol; Myocardial Contraction; Patient Selection; Propanolamines; Survival Rate; Ventricular Dysfunction, Left; Ventricular Function, Left | 2001 |
The role of race in heart failure therapy.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Black People; Coronary Artery Disease; Heart Failure; Humans; Hypertension; Incidence; Prognosis; Propanolamines; Racial Groups; Randomized Controlled Trials as Topic; Risk Factors; Ventricular Dysfunction, Left | 2002 |
3 trial(s) available for bucindolol and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
New-onset atrial fibrillation predicts heart failure progression.
Topics: Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Disease Progression; Female; Heart Failure; Humans; Male; Middle Aged; Multivariate Analysis; Prognosis; Propanolamines; Proportional Hazards Models; Risk Factors; Ventricular Dysfunction, Left | 2014 |
The incomplete bucindolol evaluation in acute myocardial infarction Trial (BEAT).
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Propanolamines; Survival Rate; Ventricular Dysfunction, Left; Ventricular Function, Left | 2002 |
Adverse effects of beta-blocker therapy for patients with heart failure: a quantitative overview of randomized trials.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Bradycardia; Carbazoles; Carvedilol; Dizziness; Fatigue; Female; Follow-Up Studies; Heart Conduction System; Heart Failure; Humans; Hypotension; Male; Metoprolol; Middle Aged; Propanolamines; Risk Factors; Risk Reduction Behavior; Severity of Illness Index; Statistics as Topic; Treatment Failure; Ventricular Dysfunction, Left; Withholding Treatment | 2004 |
2 other study(ies) available for bucindolol and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Which beta-blocker is most effective in heart failure?
Topics: Adrenergic beta-Antagonists; Animals; Benzopyrans; Bisoprolol; Carbazoles; Carvedilol; Clinical Trials as Topic; Comorbidity; Diabetes Mellitus; Disease Progression; Ethanolamines; Heart Failure; Humans; Lung Diseases, Obstructive; Metoprolol; Myocardial Infarction; Nebivolol; Propanolamines; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Remodeling | 2010 |
Hormone replacement therapy is associated with improved survival in women with advanced heart failure.
Topics: Aged; Aged, 80 and over; Arizona; California; Colorado; Estrogen Replacement Therapy; Female; Heart Failure; Humans; Louisiana; Maryland; Middle Aged; North Carolina; Ohio; Postmenopause; Prognosis; Propanolamines; Proportional Hazards Models; Randomized Controlled Trials as Topic; Retrospective Studies; Survival Analysis; Systole; Texas; Ventricular Dysfunction, Left; Virginia; Women's Health | 2003 |